Endo International Plc - Company Profile
Powered by
All the data and insights you need on Endo International Plc in one report.
$295
- Save hours of research time and resources with
our up-to-date Endo International Plc Strategy Report
- Understand Endo International Plc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
View up-to-date information on Endo International Plc’s latest deals, number of deals and deal values, alongside insights into its key mergers and acquisitions.
Number of Deals
Deal Value ($M)
Latest Deals
Announced Date | Headline | Deal Type | Acquirers/Investors/Surviving Entity | Issuer/Partner/Target |
---|---|---|---|---|
15 Jul 2022 | Endo Ventures Enters into Licensing Agreement with Quoin Pharma | Licensing Agreement |
Endo Ventures Ltd
|
Quoin Pharmaceuticals Inc
|
13 Jun 2022 | Endo Receives TLC599 Rights from Taiwan Liposome (TLC BioSciences) | Licensing Agreement |
Endo International Plc
|
Taiwan Liposome Co Ltd
|
17 May 2022 | Procaps Group to Acquire Grupo Farmaceutico Somar from Advent International | Acquisition |
Procaps Group SA
|
Grupo Farmaceutico Somar Sa De Cv
|
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
Contact the team or request a demo to find out how our data can drive your business forward
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer